Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

7.1%

2 terminated out of 28 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

39%

11 trials in Phase 3/4

Results Transparency

13%

2 of 16 completed with results

Key Signals

2 with results89% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (8)
Early P 1 (2)
P 1 (1)
P 2 (2)
P 3 (10)
P 4 (1)

Trial Status

Completed16
Unknown9
Terminated2
Recruiting1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT05890001Phase 3CompletedPrimary

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

NCT04255693Not ApplicableRecruiting

Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence

NCT07041060Not ApplicableCompletedPrimary

Evaluation of the Efficacy and Safety of Eolo in Patients With NERD

NCT05587322Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease

NCT06121830Phase 3UnknownPrimary

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)

NCT02081404Not ApplicableCompletedPrimary

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

NCT05369884Early Phase 1UnknownPrimary

Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D

NCT02788591Not ApplicableTerminatedPrimary

Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection

NCT04252144Not ApplicableUnknown

Study of Dietary Patterns and Food Diversity in Russian GERD Patients

NCT03967886Phase 3CompletedPrimary

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

NCT04324138Early Phase 1UnknownPrimary

Efficacy and Safety of Jianpi Qinghua Granules in Patients With Nonerosive Reflux Disease

NCT04759378Not ApplicableUnknown

Comorbid Esophageal Disorders in IBS Patients

NCT03444883Phase 3CompletedPrimary

Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

NCT04340297Phase 3UnknownPrimary

Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease

NCT03591653Phase 3CompletedPrimary

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks

NCT02892357Phase 1UnknownPrimary

Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease

NCT02556021Phase 3CompletedPrimary

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease

NCT02490449Not ApplicableUnknownPrimary

Dexlansoprazole MR in Nonerosive Reflux Disease

NCT02149914Not ApplicableUnknownPrimary

The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients

NCT01750437Phase 2CompletedPrimary

Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

Scroll to load more

Research Network

Activity Timeline